Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Barzolvolimab
Other

Barzolvolimab

Tracked across 1 events · 6 articles · First seen Jun 10, 2026 · Last active Jun 10, 2026

Sentiment
75
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 75
Tech
Celldex Presents Barzolvolimab, CDX-622 Data
Celldex Therapeutics announced that it will present three sets of clinical trial data for its drug candidates, Barzolvolimab and CDX-622, at the European Academy of Allergy and Clinical Immunology Annual Congress in Istanbul, Turkey, from…
Impact: Barzolvolimab is a key drug candidate for Celldex Therapeutics, with positive long-term treatment results in CSU and ColdU being presented, indicating strong potential for future market success.
Jun 10, 2026 · 6 articles
NEWSDESK
Track Barzolvolimab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.